Scholars Central

Mini reviewPublished 12 Sep 2022

Residual Hepatic HCV-RNA in the Native Liver of Living Donor Liver Transplant Recipients with Chronic Hepatitis C: Mini-Review

Authors: Shu Hsien Lin, Chih Chi Wang, Kuang Tzu Huang, Kuang Den Chen, Chih Che Lin, Li Wen Hsu, King Wah Chiu

1Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 2Liver Transplantation Center, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 3Department of Surgery, College of Medicine, Chang Gung University, Taoyuan, Taiwan; 4Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

Journal of Oncology Research and Treatment

Volume 7 · Issue 4 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic Hepatitis C Virus (HCV) infection is the leading risk factor for Hepatocellular Carcinoma (HCC), with an annual HCC risk of 2%-4% in cirrhotic patients. With the highly effective and safe direct-acting antiviral (DAA) therapy, HCV infection would be considered “cured and eliminated” successfully in >95% treated patients. However, even with the widespread use of direct-acting antivirals, Living Donor Liver Transplantation (LDLT) plays an important role in advanced liver disease. According to our recent observation, the pre-transplant serum HCV RNA levels may give an underestimate of the number of positive HCV RNA cases and that hepatic HCV RNA data may be more accurate. Herein, we would like to have a mini review to detailed address issues including the significance of hepatic HCV RNA and the discrepancy between hepatic HCV RNA and HCV core antigen in native liver of chronic hepatitis C recipients undergoing LDLT, a new insight into cure and complete elimination of HCV infection and the utilization of HCV-aviremic organs into aviremic recipients in liver transplantation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Oncology Research and Treatment.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Research and Treatment
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Shu Hsien Lin”
  • BylineArticles whose byline prints “Chih Chi Wang”
  • BylineArticles whose byline prints “Kuang Tzu Huang”
  • BylineArticles whose byline prints “Kuang Den Chen”
  • BylineArticles whose byline prints “Chih Che Lin”
  • BylineArticles whose byline prints “Li Wen Hsu”
  • BylineArticles whose byline prints “King Wah Chiu”